XIST and cancer: It is reported that XIST is dysregulated in a variety of cancers and exerts its either tumor-suppressive or oncogenic role in tumorigenesis and progression of cancers, such as hepatocellular carcinoma, lung cancer, gastric cancer, and osteosarcoma (95–97).